2019 has brought a plethora of CBD products that continue to bolster existing product categories and pique the interest of millions of new consumers. One product category that has gained a great deal of [...]

Science forms the basis for decisions at the U.S. Food and Drug Administration (FDA) and is paramount when it comes to making decisions that will impact the health and safety of the American public. [...]

Today, the U.S. Food and Drug Administration announced that it has issued a warning letter to Curaleaf Inc., of Wakefield, Massachusetts, for illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that [...]